Well, they certainly need cash for their acquisitions.
These acquisitions, while crucial to success, are material and we need to know the cost and have a better sense of the dilution aspect.
I am of the feeling that while canada is far from 'played out', one needs to now focus more on US and international coming approvals, both medical and recreational, which imo is not really that far away.
The major canadian company's look well positioned or poised to be big players in those areas in the days to come.
The biggest current play right now, imo, remains in positioning oneself with companys poised to benefit from hemp legalization, clearly about to happen very soon.
Compnys like CVSI, Canopy, Aurora and Aphria are especially well positioned already to benefit from hemp legalization.
MedMen might also be, but we don't know yet.
News 
Market Data 
Discover 
